2.80
price down icon1.75%   -0.05
after-market Handel nachbörslich: 2.76 -0.04 -1.43%
loading

Cabaletta Bio Inc Aktie (CABA) Neueste Nachrichten

pulisher
Feb 13, 2026

Pharma News: Why retail investors favor Cabaletta Bio Inc. stock2025 Historical Comparison & Fast Entry High Yield Tips - mfd.ru

Feb 13, 2026
pulisher
Feb 13, 2026

Cabaletta Bio Kicks Off Pivotal Myositis Trial, Touts Automated CAR-T Manufacturing Path to 2027 BLA - Yahoo Finance

Feb 13, 2026
pulisher
Feb 12, 2026

Is Anavex Life Sciences (AVXL) Stock Outpacing Its Medical Peers This Year? - Nasdaq

Feb 12, 2026
pulisher
Feb 11, 2026

Aug Drivers: Is Cabaletta Bio Inc stock a smart retirement pickJuly 2025 Recap & Fast Moving Market Watchlists - baoquankhu1.vn

Feb 11, 2026
pulisher
Feb 11, 2026

CABA News Today | Why did Cabaletta Bio stock go up today? - MarketBeat

Feb 11, 2026
pulisher
Feb 09, 2026

Exit Recap: Is SpartanNash Company stock risky to hold nowJuly 2025 Review & Real-Time Volume Trigger Notifications - baoquankhu1.vn

Feb 09, 2026
pulisher
Feb 09, 2026

Cabaletta Bio Takes Spotlight at Guggenheim Summit as Autoimmune Bet Advances - MyChesCo

Feb 09, 2026
pulisher
Feb 06, 2026

Update Recap: Is Cabaletta Bio Inc stock overvalued or fairly priced2025 Macro Impact & AI Powered Market Entry Strategies - baoquankhu1.vn

Feb 06, 2026
pulisher
Feb 06, 2026

Trend Review: Is Cabaletta Bio Inc stock overvalued or fairly pricedJuly 2025 Technicals & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn

Feb 06, 2026
pulisher
Feb 06, 2026

Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - The Globe and Mail

Feb 06, 2026
pulisher
Feb 05, 2026

Cabaletta Bio to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026 - Quiver Quantitative

Feb 05, 2026
pulisher
Feb 05, 2026

Risk Off: What is Cabaletta Bio Incs P E ratio telling usJuly 2025 PostEarnings & Weekly High Return Stock Forecasts - baoquankhu1.vn

Feb 05, 2026
pulisher
Feb 03, 2026

Swing Trade: Can Cabaletta Bio Inc deliver consistent dividendsQuarterly Earnings Summary & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn

Feb 03, 2026
pulisher
Feb 01, 2026

US Market Wrap: Can Cabaletta Bio Inc disrupt its industryJuly 2025 Outlook & Reliable Entry Point Alerts - baoquankhu1.vn

Feb 01, 2026
pulisher
Jan 31, 2026

Highs Report: Will Tucows Inc outperform its industry peersMarket Activity Recap & Fast Moving Stock Trade Plans - baoquankhu1.vn

Jan 31, 2026
pulisher
Jan 30, 2026

What makes Cabaletta Bio, Inc. (CABA) a strong momentum stock: Buy now? - MSN

Jan 30, 2026
pulisher
Jan 30, 2026

What Makes Cabaletta Bio, Inc. (CABA) a Strong Momentum Stock: Buy Now? - Yahoo Finance

Jan 30, 2026
pulisher
Jan 28, 2026

Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Jan 28, 2026
pulisher
Jan 27, 2026

Guggenheim reiterates Buy rating on Cabaletta Bio stock, citing commercial plan - Investing.com Nigeria

Jan 27, 2026
pulisher
Jan 27, 2026

Cabaletta Bio: Do You Buy With The Insiders? (NASDAQ:CABA) - Seeking Alpha

Jan 27, 2026
pulisher
Jan 27, 2026

Is Cabaletta Bio (CABA) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Jan 27, 2026
pulisher
Jan 27, 2026

Largest borrow rate increases among liquid names - TipRanks

Jan 27, 2026
pulisher
Jan 26, 2026

Assessing Cabaletta Bio (CABA) Valuation After Insider Buying And FDA Clearance For Automated CAR T Manufacturing - Yahoo Finance

Jan 26, 2026
pulisher
Jan 26, 2026

Can Cabaletta Bio’s (CABA) Shift To Automated CAR T Manufacturing Redefine Its Scalability Edge? - simplywall.st

Jan 26, 2026
pulisher
Jan 25, 2026

Stock Analysis: Does Cabaletta Bio Inc have pricing powerWeekly Trend Recap & Daily Growth Stock Investment Tips - baoquankhu1.vn

Jan 25, 2026
pulisher
Jan 25, 2026

Strategic Partnerships Propel Cabaletta Bio Forward - StocksToTrade

Jan 25, 2026
pulisher
Jan 25, 2026

Cabaletta Bio Unveils Strategic Plans Amid Price Target Revision - timothysykes.com

Jan 25, 2026
pulisher
Jan 24, 2026

Cabaletta Bio Aims High with Strategic Initiatives for 2026​ - StocksToTrade

Jan 24, 2026
pulisher
Jan 24, 2026

Steven Nichtberger Bought 3.3% More Shares In Cabaletta Bio - Sahm

Jan 24, 2026
pulisher
Jan 23, 2026

Returns Recap: Is Cabaletta Bio Inc stock trending bullishGap Down & Community Verified Trade Signals - baoquankhu1.vn

Jan 23, 2026
pulisher
Jan 23, 2026

Cabaletta Bio Unveils Strategic Plans Amid Financial Forecast Changes - StocksToTrade

Jan 23, 2026
pulisher
Jan 23, 2026

Cabaletta Bio Stock (CABA) Opinions on Insider Buying and Clinical Updates - Quiver Quantitative

Jan 23, 2026
pulisher
Jan 23, 2026

Cabaletta targets 2027 FDA filing as autoimmune CAR-T push accelerates - MSN

Jan 23, 2026
pulisher
Jan 23, 2026

Cabaletta Bio Advances Rese-cel Toward Pivotal Milestones, Expands Autoimmune Cell Therapy Pipeline - RTTNews

Jan 23, 2026
pulisher
Jan 23, 2026

Why Cabaletta Bio (CABA) Is Up 41.3% After FDA Clears Automated CAR T Manufacturing Platforms - Yahoo Finance

Jan 23, 2026
pulisher
Jan 23, 2026

Cabaletta Bio to Present Pioneering Clinical Data on Rese-cel at Major Scientific Conferences - MSN

Jan 23, 2026
pulisher
Jan 22, 2026

Cabaletta Bio Sees Unusually Large Options Volume (NASDAQ:CABA) - MarketBeat

Jan 22, 2026
pulisher
Jan 22, 2026

Cabaletta Bio (CABA) Shares Surge 11% After Insider Buying - GuruFocus

Jan 22, 2026
pulisher
Jan 22, 2026

Cabaletta Bio stock jumps 11% premarket after insider buying cluster hits the tape - TechStock²

Jan 22, 2026
pulisher
Jan 22, 2026

Cabaletta Bio, Inc. (NASDAQ:CABA) institutional owners may be pleased with recent gains after 9.7% loss over the past year - simplywall.st

Jan 22, 2026
pulisher
Jan 22, 2026

Cabaletta Bio (CABA) CEO Nichtberger buys $100,777 in shares By Investing.com - Investing.com UK

Jan 22, 2026
pulisher
Jan 21, 2026

Biotech Stocks Surge After Hours: IO Biotech Jumps 19%, Cue Biopharma And Cabaletta Bio Follow - Nasdaq

Jan 21, 2026
pulisher
Jan 21, 2026

Cabaletta Bio Insiders Go on a Buying Spree, Signaling Strong Confidence From the Top - TipRanks

Jan 21, 2026
pulisher
Jan 21, 2026

Insider Buying: Michael Gerard Acquires Shares of Cabaletta Bio Inc (CABA) - GuruFocus

Jan 21, 2026
pulisher
Jan 21, 2026

Insider Buying: Steve Gavel Acquires Shares of Cabaletta Bio Inc (CABA) - GuruFocus

Jan 21, 2026
pulisher
Jan 21, 2026

Steven Nichtberger Acquires 45,000 Shares of Cabaletta Bio (NASDAQ:CABA) Stock - MarketBeat

Jan 21, 2026
pulisher
Jan 21, 2026

Cabaletta Bio (NASDAQ:CABA) Director Mark Simon Acquires 11,061 Shares - MarketBeat

Jan 21, 2026
pulisher
Jan 21, 2026

Cabaletta Bio (NASDAQ:CABA) Insider Gwendolyn Binder Buys 11,312 Shares - MarketBeat

Jan 21, 2026
pulisher
Jan 21, 2026

Insider Buying: Cabaletta Bio (NASDAQ:CABA) Insider Acquires 8,800 Shares of Stock - MarketBeat

Jan 21, 2026
pulisher
Jan 21, 2026

Michael Gerard Purchases 6,600 Shares of Cabaletta Bio (NASDAQ:CABA) Stock - MarketBeat

Jan 21, 2026
pulisher
Jan 21, 2026

Cabaletta Bio (NASDAQ:CABA) Director Shawn Tomasello Acquires 22,725 Shares - MarketBeat

Jan 21, 2026
pulisher
Jan 21, 2026

Cabaletta Bio (NASDAQ:CABA) Insider Acquires 22,170 Shares - MarketBeat

Jan 21, 2026
$26.45
price down icon 1.12%
$45.19
price up icon 0.87%
$101.10
price up icon 0.35%
$105.87
price up icon 0.10%
$148.75
price up icon 1.77%
biotechnology ONC
$346.07
price down icon 0.10%
Kapitalisierung:     |  Volumen (24h):